Maravai Lifesciences Holdings (MRVI) EBIT Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 100.00% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 12.69% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 75.16% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -347.04% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 1.27% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -230.00% |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 80.62% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | 95.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.61% |
| Dec 31, 2025 | -55.95% |
| Sep 30, 2025 | 75.22% |
| Jun 30, 2025 | -393.14% |
| Mar 31, 2025 | -160.65% |
| Dec 31, 2024 | -427.30% |
| Sep 30, 2024 | -974.23% |
| Jun 30, 2024 | -15.72% |
| Mar 31, 2024 | -844.61% |
| Dec 31, 2023 | -106.54% |
| Sep 30, 2023 | -113.19% |
| Jun 30, 2023 | -106.43% |
| Mar 31, 2023 | -98.49% |
| Dec 31, 2022 | -29.31% |
| Sep 30, 2022 | -24.76% |
| Jun 30, 2022 | 17.69% |
| Mar 31, 2022 | 83.54% |
| Dec 31, 2021 | 394.61% |
| Sep 30, 2021 | 239.84% |
| Jun 30, 2021 | 1,790.83% |